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Abstract: The present in vitro study created nanometer crystalline hydroxyapatite (HA) and 
amorphous calcium phosphate for novel orthopedic applications. Specifically, nano-crystalline 
HA and amorphous calcium phosphate nanoparticles were synthesized by a wet chemical process 
followed by hydrothermal treatment for 2 hours at 200°C and 70°C, respectively. Resulting 
particles were then pressed into compacts. For the preparation of control conventional HA 
particles (or those currently used in orthopedics with micron diameters), the aforementioned 
calcium phosphate particles were pressed into compacts and sintered at 1100°C for 2 hours. 
All calcium phosphate-based particles were fully characterized. Results showed that although 
there was an initial weight gain for all the compacts studied in this experiment, higher eventual 
degradation rates up to 3 weeks were observed for nano-amorphous calcium phosphate compared 
with nano-crystalline HA which was higher than conventional HA. Peptide functionalization 
(with the cell adhesive peptide lysine-arginine-serine-arginine [KRSR] and the non-cell-adhesive 
peptide lysine-serine-arginine-arginine [KSRR]) was accomplished by means of a three-step 
reaction procedure: silanization with 3-aminopropyltriethoxysilane (APTES), cross-linking 
with N-succinimidyl-3-maleimido propionate (SMP), and finally peptide immobilization. The 
peptide functionalization was fully characterized. Results demonstrated increased osteoblast 
(bone-forming cell) adhesion on non-functionalized and functionalized nano-crystalline 
HA compacts compared with nano amorphous calcium phosphate compacts; both increased 
osteoblast adhesion compared with conventional HA. To further exemplify the novel properties of 
nano crystalline HA, results also showed similar osteoblast adhesion between non-functionalized 
nano crystalline HA and KRSR functionalized conventional HA. Thus, results provided evidence 
that nanocrystalline HA should be further studied for orthopedic applications.
Keywords: nanomaterials, hydroxyapatite; osteoblast adhesion; KRSR grafting 
Introduction
A number of applications require bone-building agents; for example, although 
osteoporosis has been studied for a number of years, no current effective prevention 
and treatment methods exist for this disease. It is clear, however, that low bone mass 
is a strong predictor of future fractures and this risk occurs during the normal course 
of aging, during unloading of the skeleton (eg, bed-rest after surgery, lack of exercise), 
as a consequence of certain diseases (such as arthritis and osteoporosis), and as a 
side-effect of various drug therapies (eg, hormone replacements, steroids). Various 
countermeasures (specifically, drugs, diet, and physical activity) have been developed 
and studied for the prevention and treatment of clinical osteoporosis (Barbucci 2002). 
None have experienced overwhelming success. 
For example, several major barriers exist for the use of any pharmaceutical agents 
to stimulate new bone formation. First, these agents can cause non-specific bone 
formation in areas not selectively affected with a bone disease, because these agents 
are often delivered in non-specific ways (such as through the mouth or directly into the 
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blood stream). Second, if delivered locally to the tissue around 
the area of low bone density, they rapidly diffuse to adjacent 
tissues which limits their potential to promote prolonged bone 
formation in targeted areas of weak osteoporotic bone. 
In terms of material solutions (ie, implants) to treat 
changes in bone mass, the story is not any better. For 
example, orthopedic implant materials (or fixation devices) 
are used when changes in bone mass lead to debilitating 
fractures (American Academy of Orthopedic Surgeons 2004). 
Unfortunately, the average lifetime of current orthopedic 
implants is only 10–15 years (Emery et al 1997). It is the hope 
that new materials will repair bone non-unions quickly and 
effectively so that the patient can return to a normal healthy 
life-style and not require several implant revision surgeries 
in their lifetime.
One promising set of materials for both delivering drugs 
and to increase bone mass is calcium phosphates (Otsuka 
et al 1994, 1997; Nimni 1997; Ruhe et al 2003). Calcium 
phosphate-based biomaterials have been is use in medicine 
and dentistry for more than two decades (Hoexter 2002; 
Sammarco et al 2002). One category of calcium phosphate-
based materials, hydroxyapatite, arises from its similarity 
to bone as it is the major inorganic component. Particularly, 
hydroxyapatite (HA; Ca10(PO4)6(OH)2) possesses excellent 
biocompatibility and is osteoconductive (Wang 2004). HA 
can be produced using a variety of methods such as wet 
chemistry (precipitation), hydrothermal techniques, sol-gel, 
and hydrolysis of calcium phosphates (Wang 2004). The 
characteristics of the resulting HA particulates have significant 
effects on its performance to regrow bone (Wang 2004).
One material property that may influence the ability 
of HA and other calcium phosphate-based materials to 
promote bone growth is grain size. Specifically, compared 
with micron grain sizes, significant evidence now exists that 
ceramics, metals, polymers, and composites thereof with 
nanometer grain sizes stimulate osteoblast (bone-forming 
cells) activity leading to more bone growth (Webster et al 
2001; Kay et al 2002; Webster and Ejiofor 2004; Webster 
and Smith 2005). In addition to their ability to promote 
new bone growth when used as implants, it is believed that 
nanoparticles can be formulated to selectively attach to areas 
of osteoporotic (not healthy) bone by either direct attachment 
to weak bone to release pharmaceutical agents at the site of 
need or by directing them to weak bone by external signals 
(such as magnetic particles coated with HA) (Gupta and 
Gupta 2005).
As a first step in this direction, the objective of this in vitro 
study was to develop functionalized calcium phosphate-based 
nanoparticles that could in the future be used either in drug 
delivery or as orthopedic implants to promote bone growth. 
Lysine-arginine-serine-arginine- (KRSR) containing peptides 
were used as model functionalizing agents in this study. 
KRSR peptides have been shown to promote the selective 
adhesion of osteoblasts while, at the same time, inhibit the 
adhesion of soft-tissue forming cells like fibroblasts (Dee et 
al 1998). An interesting approach that underlies this present 
study is whether the nanoscale features of the underlying 
calcium phosphate-based materials have a significant 
influence on osteoblast cell adhesion due to the presence of 
KRSR functionalization. 
Materials and methods
Materials
3-aminopropyltriethoxysilane (APTES), N,N,-dimethyl-
formamide (DMF), N-succinimidyl-3-maleimido propionate 
(SMP), and n-hexane were purchased from Sigma-Aldrich 
(St Louis, MO, USA). Peptides were purchased from EZ 
Biolab, USA.
Synthesis of nano-amorphous calcium 
phosphate, nano-crystalline HA, and 
conventional HA compacts
The process used to synthesize the calcium phosphate-based 
particles is outlined below in equation 1. Specifically, HA was 
precipitated through a well-established wet chemical process 
(Wang 2004; Sato et al 2005). Concentrated ammonium 
hydroxide was used to maintain the reaction mixture at a pH 
of 10 throughout the reaction. 0.6M ammonium phosphate 
and 1.0M calcium nitrate were also added slowly (3.6mL/
min). Calcium phosphate precipitation occurred while 
stirring for 20 hours at room temperature.
10Ca(NO3)2 + 6(NH4)2HPO4 + 8NH4OH  →  
Ca10(PO4)6(OH)2+6H2O + 20NH4NO3 (1)
For the preparation of nano-amorphous calcium phosphate, 
the above-mentioned precipitated particles were treated 
hydrothermally at 70°C for 20 hours (Sato et al 2005). 
The white powder thus obtained was dried under vacuum 
(10
–5 Torr) prior to pressing into compacts.
For the preparation of nano-crystalline HA, the 
above-mentioned precipitated particles were processed 
hydrothermally at 200°C for 20 hours. As a result, nano-sized 
crystalline HA can be obtained (Balasundaram et al 2006). 
The resulting particles (both amorphous calcium 
phosphate and nano-crystalline HA) were then separately International Journal of Nanomedicine 2006:1(3) 341
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crushed and pressed into compacts (approximately 10 mm 
in diameter and 1–1.5 mm in height) via a uniaxial pressing 
cycle that reached up to 1 GPa over a 10-min period. For the 
preparation of conventional HA, the pressed nano-amorphous 
calcium phosphate compacts were sintered at 1100°C in air 
for 2 hours (with a kiln ramp rate of 22°C/min).
Degradation experiment of compacts in 
cell culture media 
The pressed compacts (calculated amount) were incubated 
in Dulbecco’s Modified Eagle Medium (DMEM; Gibco) 
cell culture media supplemented with 10% fetal bovine 
serum (Hyclone) and 1% penicillin–streptomycin (Gibco) 
at 37°C for 1–21 days to evaluate their degradation. The 
weight loss of the compacts were measured and recorded as 
the degradation profile. Standard t-tests were used to check 
statistical significance between means. Experiments were 
conducted in triplicate and repeated three times each.
Peptide synthesis 
The peptide epitope KRSR (KRSRGYC) represents a model 
cell adhesive domain which was used in this study to develop 
a versatile functionalization method. KSRR (KSRRGYC) 
was used in the present study as a non-cell-adhesive negative 
control peptide. Both peptides were obtained as carboxyl-
terminal acids to more than 98% purity according to the 
HPLC profile provided by the manufacturer.
Compact functionalization
Compact functionalization was conducted under anhydrous 
conditions in order to avoid surface contamination from the 
surrounding atmosphere and hence ensure reproducibility 
as well as stability of the biomolecules. The strategy of 
peptide immobilization (Figure 1) involved: (i) grafting of 
an amino-functional organosilane (APTES) onto the surface 
of calcium phosphate-based materials and (ii) substituting 
the terminal amine for a hetero-bifunctional cross-linker 
SMP in order to (iii) react the outer maleimide group with 
the peptide that possessed the terminal thiol group present 
in cysteine. Experimentally, functionalization of the calcium 
phosphate-based nanoparticles was performed according 
to the procedure presented in Figure 1. Silanization was 
carried out by immersing the compacts in a solution of 
APTES (1×10
–2 M) in anhydrous hexane for 2 hours (while 
stirring) followed by cleaning with hexane several times. 
Silanized compacts were outgassed at 30°C in vacuum 
conditionS (10
–5 Torr) for 4 hours and were treated with SMP 
(2×10
–3 M) in N, N-dimethylformamide (DMF) for 2 hours. 
Compacts were cleaned with hexane several times using 
stirring and sonication, and were outgassed at 30°C under 
vacuum conditionS (10
–5 Torr) for several hours. Peptides 
were immobilized onto calcium phosphate-based compacts 
in anhydrous DMF (1 mM) for 2 hours. Finally, compacts 
were washed with DMF followed by several washes with 
deionized water.
Surface characterization
Particle characterization
Material properties of the calcium phosphate-based particles 
were determined by X-ray diffraction using Cu-Kα radiation 
(Siemens D500 Kristalloflex; Bruker AXS Inc.), inductively 
coupled plasma-atomic emission spectroscopy (ICP-AES, 
Impact Analytical, Midland, MI, USA) to measure Ca/P ratio, 
nanometer particle size analyzer (COULTER LS 230; Coulter 
Corporation, FL, USA) to measure the mean particle size, 
and BET (Brunauer, Emmet, Teller) to measure agglomerate 
particle size. Standard techniques were followed for each of 
the characterization methods (Sato et al 2005). 
Chemical functionalization characterization
Surface chemical functionalization was determined by X-ray 
photoelectron spectroscopy (XPS). XPS spectra were recorded 
with a Kratos Analytical spectrometer on plain and peptide 
functionalized compacts. Power of the non-monochromatized 
Figure 1  Reaction scheme for functionalizing peptides on calcium phosphate-
based materials. In the present study, peptides were KRSR (experimental) and 
KSRR (negative control).
Abbreviations: APTES, amino-functional organosilane; DMF, 
dimethylformamide; SMP, N-succinimidyl-3-maleimido propionate.International Journal of Nanomedicine 2006:1(3) 342
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MgKa source was 200 W with an investigated area of about 
250 µm. The compacts were mounted on a sample stub with 
conductive carbon tape. After acquisition, fitting was then 
completed with software provided by Kratos Vision II; 
binding energy (BE) values were ± 0.2 eV . 
Cell experiments
Adhesion 
Compacts were sterilized under UV light for 4 hours prior 
to cell experiments. Human osteoblasts (bone-forming cells; 
CRL-11372 American Type Culture Collection, population 
numbers 7–8) in DMEM supplemented with 10% fetal 
bovine serum and 1% penicillin–streptomycin were seeded 
at a density of 3500 cells/cm
2 onto the compacts of interest 
and were then incubated in an atmosphere of 5% CO2/95% 
air at 37°C for 4 hours. After the prescribed time period, 
substrates were rinsed in phosphate buffered saline to remove 
any non-adherent cells. The remaining cells were fixed 
with formaldehyde (Sigma), stained with Hoescht 33258 
dye (Sigma), and counted under a fluorescence microscope 
(Leica, DMIRB; Leica Microsystems, Germany). Cell counts 
were completed in five fields chosen randomly per cm
2 of 
substrate surface area. All experiments were run in triplicate 
and repeated at least three separate times. Standard t-tests 
were used to check statistical significance between means.
Morphology 
The morphology of osteoblasts adherent on the various 
compacts of interest to this study was characterized using a 
scanning electron microscope (SEM, JEOL JSM-840). For 
SEM analysis, compacts were first sputter-coated with a thin 
layer of gold-palladium using a Hummer I Sputter Coater 
(Technics) in a 100 mTorr vacuum argon environment for 
a 3-min period at 10 mA of current. Images were taken at a 
5 kV accelerating voltage. Digital images were recorded using 
Digital Scan Generator Plus (JEOL) software. 
Results 
Material synthesis
Particle synthesis
Nano-amorphous calcium phosphate, nano-crystalline 
HA, and conventional HA particles were successfully 
synthesized. Material properties of the nano-amorphous 
calcium phosphate, nano-crystalline HA, and conventional 
HA particles are summarized in Table 1. Specifically, X-ray 
diffraction provided evidence of only one material phase in 
both nano-crystalline HA and conventional HA, while no 
crystalline phases were determined for the nano-amorphous 
calcium phosphate particles. BET provided evidence 
that nano-crystalline HA and nano-amorphous calcium 
phosphate had 31 and 13 nm particle sizes, respectively, 
while conventional HA possessed a particle size of 7400 nm. 
All particle types significantly agglomerated into micron 
sizes; specifically, nano-crystalline HA and nano-amorphous 
calcium phosphate agglomeration sizes were 5.21 and 
8.84 µm, respectively, while conventional HA agglomerated 
to 169 µm. Lastly, nano-crystalline HA and nano-amorphous 
calcium phosphate particle shapes were irregular while 
conventional HA possessed cylindrical shapes. 
Compact synthesis
As expected, when the aforementioned particles were 
compacted, SEM analysis provided evidence of increased 
nanometer surface roughness for the nano-amorphous 
calcium phosphate compared with nano-crystalline HA; 
compacts of nano-crystalline HA appeared more rough 
than conventional HA compacts (Figure 2). The specific 
surface area of nano-amorphous calcium phosphate (Figure 
Table 1  Summary of material properties of nano-amorphous calcium phosphate, nano-crystalline HA, and conventional HA
Characterization  Nano-amorphous  Nano crystalline HA  Conventional HA 
    calcium phosphate
Crystalline phase  –  HA  HA
Ca/P ratio  1.66  1.61  1.63
BET surface area (m
2/g)  142.11  62.165  0.26
(Crystallite or particle size [nm])  (13)  (31)  (7400)
Agglomerate particle size [µm]   8.78  4.84  120
(Median [µm])   (8.84)  (5.21)  (169)
Particle morphology  Irregular shape  Irregular shape  Cylindrical
Degradation
a  High (3 mg/day)  Low (2.14 mg/day)  Very low (0.29 mg/day)
aDegradation taken between 14 and 21 days of immersion in cell culture media.
Abbreviations: HA, hydroxyapatite. International Journal of Nanomedicine 2006:1(3) 343
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2a) synthesized and processed at low temperatures was 
significantly larger than that of nano-crystalline HA (Figure 
2b). Further, SEM analysis revealed significant morphological 
transformations when nano-crystalline HA was sintered to 
conventional HA (Figure 2c). 
Degradation of compacts in cell culture 
media 
Degradation experiments for all compacts in cell culture 
media showed higher degradation rates for nano-amorphous 
calcium phosphate compared with nano-crystalline HA, 
which was higher than conventional HA (Figure 3). The 3-
week degradation experiment revealed a linear weight change 
for all compacts studied between 7 and 21 days. In all cases, 
the weight of the tablets initially increased before decreasing. 
Specifically, nano-amorphous calcium phosphate displayed a 
sharp increase in weight followed by a linear weight decrease 
(Figure 3a). Though nano-crystalline HA showed an initial 
weight gain, it showed a comparatively slower degradation 
rate compared with nano-amorphous calcium phosphate 
(Figure 3b). However, conventional HA demonstrated very 
little increase in weight and a low subsequent degradation 
compared with both nano-amorphous calcium phosphate and 
nano-crystalline HA (Figure 3c). In particular, the weight 
difference among the compacts between 14 and 21 days 
showed that nano-amorphous calcium phosphate had 21 mg 
of weight loss, nano-crystalline HA had 15 mg of weight loss, 
and conventional HA had 2 mg of weight loss.
Chemical functionalization 
The peptide sequences chosen for the biofunctionalization 
were KRSRGYC and KSRRGYC. Importantly, Ca 2p and 
P 2p peaks were found for all three plain substrates as 
expected. For example, as shown in Figures 4a4 and 4b4, 
plain (unfunctionalized) nanocrystalline HA displayed Ca 
2p (350.2 eV–352.1 eV) and P 2s peaks (135.7 eV–136.5 eV), 
respectively. However, for the peptide-functionalized 
substrates, detection of these two elements was less obvious 
due to the outer layer of peptide functionalization (Figures 
4a1–4a3 and 4b1–4b3). This provided an indication of the 
coverage of silane and peptide moieties on the functionalized 
compacts. Similar results were obtained for all compacts 
functionalized with the negative control KSRR peptide (data 
not shown).
Importantly, for the functionalized surfaces, XPS analysis 
further confirmed the presence of Si, N, and S, in addition 
to the expected Ca and P from HA. The Si 2p XPS spectrum 
showed one maximum component at 103.3 eV which 
corresponded to the typical SiO3 bonding (Figures 5a1–5a3). 
Figure 2  Scanning electron microscopy images of calcium phosphate-based compacts. Increased compact surface roughness was observed on (a) nano-amorphous 
calcium phosphate compared with (b) nano-crystalline HA and (c) conventional HA. Bars = 10 µm.
Figure 3  Degradation profile of calcium phosphate-based materials in DMEM. 
Data = mean ± SEM; n = 3; * p <0.01 (compared with respective substrate at 0 
days); ** p <0.01 (compared with conventional HA weight loss over the entire 
time period); and *** p <0.01 (compared with nano-crystalline HA weight loss 
over the entire time period).
Abbreviations: HA, hydroxyapatite. 
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Figure 4  X-ray photoelectron spectroscopy analysis of Ca 2p, P 2p for KRSR peptide-functionalized compared with non-functionalized materials. 
Abbreviations: CPS, counts per second; HA, hydroxyapatite.
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Figure 2
In addition, the N 1s spectrum revealed two components: one 
of low energy (characteristic of C-NH2 groups at 400.3 eV) 
and another one at 402.3 eV which can be attributed to N 
involved in the oxidized environment (Figures 5b1–5b3). 
This result may be due to some interactions between the 
terminal amino group and O groups near the surface. From 
all these observations, it is clear that the siloxane and amino 
acid chains were well grafted onto the surface of the particles, International Journal of Nanomedicine 2006:1(3) 345
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a critical condition for subsequent peptide attachment. 
After the cross-linker molecule, SMP, and peptide grafting, 
XPS analysis confirmed the increase in N content (Figures 
5b1–5b3) due to the presence of N in every amino acid of the 
peptide and the presence of S (Figure 5c1–5c3) which came 
from the cysteine amino acid of the peptide. The presence of 
S 2p (which came from thiol groups of the cysteine amino 
acid) at 153.8 eV–155.3 eV confirmed peptide attachment. 
Figure 5  X-ray photoelectron spectroscopy analysis of Si 2p, N 1s, S 2p for KRSR peptide functionalized compared with non-functionalized materials. 
Abbreviations: CPS, counts per second; HA, hydroxyapatite.
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Cell adhesion
As expected, the results obtained from cell adhesion 
experiments showed greater adhesion of osteoblasts to 
nano-amorphous calcium phosphate and conventional HA 
compacts functionalized with KRSR compared with either 
respective compacts functionalized with KSRR or the non-
functionalized (plain) compacts (Figure 6). Most strikingly, 
osteoblast adhesion on nano-crystalline HA functionalized 
with KSRR was statistically higher than nano-amorphous 
calcium phosphate and conventional HA functionalized with 
KRSR (3275 cells/cm
2 for nano-crystalline HA compared 
with 2125 and 1030 cells/cm
2 for nano-amorphous calcium 
phosphate and conventional HA, respectively). The same 
trend was observed with the plain, non-functionalized, 
substrates. Furthermore, as expected, the non-adhesive 
peptide KRSR displayed decreased cell adhesion compared 
with KRSR on nano-amorphous calcium phosphate and 
conventional HA. Interestingly, for nano-crystalline HA, 
the non-adhesive, negative-control, peptide KSRR displayed 
similar cell adhesion compared with the KRSR peptide. 
Also, non-functionalized nano-crystalline HA displayed 
similar cell adhesion compared with KRSR functionalized 
on conventional HA. In this manner, this study provided the 
first evidence that the benefits of immobilizing KRSR on 
conventional HA can be matched by using non-functionalized 
nano-crystalline HA.
Osteoblast morphology 
Osteoblast morphology results confirmed quantitative results 
(Figure 7). Specifically, attached cells were more widespread 
on the nano-crystalline HA (Figure 7b) compared with nano-
amorphous calcium phosphate (Figure 7a) and conventional 
HA (Figure 7c) after 4 hours of incubation. Osteoblasts were 
better spread on nano-amorphous calcium phosphate than on 
conventional HA. 
Discussion
Interactions between cell-membrane integrin receptors 
and extracellular matrix proteins are often facilitated by 
constituent arginine-glycine-aspartic acid (RGD) amino 
acid sequences (Ruoslahti et al 1987; Rezania et al 1997; 
Xioa et al 1998; Anselme et al 2000; Schaffner et al 2003). 
These interactions are important for the adhesion of many 
cells types. Integrin-mediated cell attachment influences 
and regulates cell spreading, migration, proliferation, 
differentiation, and apoptosis (Hughes et al 1993; Saito et 
al 1994; Schneider et al 1994). Further, in a recent study, it 
was observed that decreasing the particulate size of calcium 
phosphate-based materials into the nanometer regime 
Figure 6  Increased osteoblast adhesion on nano-crystalline HA compacts 
functionalized with KRSR. Data = mean ± SEM; n = 3; * p <0.01 (compared with 
respective plain substrate); ** p <0.01 (compared with respective conventional 
HA functionalization); and *** p <0.01 (compared with respective nano-
crystalline HA functionalization).
Abbreviations: HA, hydroxyapatite; SMP, N-succinimidyl-3-maleimido 
propionate.
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Figure 7  Scanning electron microscopy images of osteoblasts attached to calcium phosphate-based compacts. Increased cell spreading was observed on  
nano-crystalline HA compared with nano-amorphous calcium phosphate and conventional HA. Bars = 10 µm.
Abbreviations: HA, hydroxyapatite. 
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and reducing crystallinity promoted osteoblast adhesion 
to the same degree as the well-established techniques of 
functionalizing conventional HA with RGD (Balasundaram 
et al 2006). This speaks to the promise nanostructured 
materials have in promoting osteoblast adhesion to a similar 
degree to that of well-established peptide immobilization 
techniques.
However, RGD does not completely account for all 
osteoblast adhesion mechanisms; other mechanisms of cell 
adhesion are clearly involved (Puleo et al 1992; Dalton 
et al 1995). For example, cell-membrane heparin sulfate 
proteoglycan interactions with heparin-binding sites on 
extracellular matrix proteins (such as fibronectin and 
collagen) also regulate osteoblast adhesion (Dee et al 1998). 
While integrin-binding peptides (for example, RGD) have 
been successfully immobilized on substrates to partially 
control osteoblast adhesion, minimal, bioactive, peptide 
sequences that enhance proteoglycan-mediated osteoblast 
adhesion (such as the presently examined KRSR) need 
to be considered. KRSR has recently been recognized as 
a prominent peptide sequence that specifically increases 
osteoblast adhesion compared with other cells (such as 
fibroblasts and endothelial cells) (Dee et al 1998). Coating 
implant surfaces with KRSR appears to be promising, 
although previous research demonstrates that KRSR, while 
selective for osteoblasts, does not reach the efficiency of 
the RGD peptide towards promoting osteoblast adhesion 
(Hassenbein et al 2002). Due to the importance of KRSR 
in mediating osteoblast adhesion, the present in vitro study 
focused on the covalent immobilization of the KRSR peptide 
onto calcium phosphate-based nanoparticles using silane 
derivative spacer arms. 
For the first time, this paper represents an attempt to 
advance design criteria utilized for improving osteoblast 
adhesion on calcium phosphate-based materials in two ways: 
through the use of (i) nanometer crystalline HA particles and 
(ii) chemical covalent attachment techniques. Since this study 
demonstrated greater osteoblast adhesion on nano-crystalline 
HA compared with conventional (or micron grain size) HA, 
the present study adds nano-crystalline HA to the growing 
list of materials that, when created to possess constituent 
nanometer particulates, promote osteoblast adhesion. Since 
the adhesion of osteoblasts is a necessary prerequisite for 
subsequent cell functions (such as the deposition of calcium-
containing mineral), this study also implies further enhanced 
functions of osteoblasts on nano-crystalline HA compared 
with conventional HA; clearly, however, more studies would 
be needed to verify this. 
In this light, the present results of similar osteoblast 
adhesion on non-functionalized nano-crystalline HA 
compared with conventional HA functionalized with KRSR 
cannot be underestimated. Such data exemplify the potential 
advances that can be made in promoting osteoblast adhesion 
by using nanometer particles without complicated chemical 
immobilization techniques on conventional materials. 
However, the present results of increased osteoblast adhesion 
on plain and functionalized nano crystalline HA compared 
with nano-amorphous calcium phosphate contradicts that of 
a previous study. Specifically, a previous study highlighted 
greater osteoblast adhesion on non-functionalized nano-
amorphous calcium phosphate compared with nano-
functionalized nano-crystalline HA (Balasundaram et al 
2006). This contradiction is unclear at this point and requires 
more experiments especially since the material property 
characterization results in this study matched those of the 
previous study (Balasundaram et al 2006). Probable reasons 
for this could be: (i) the hydrophilic property of the nano-
amorphous calcium phosphate may have a high affinity with 
the positively charged KRSR moiety, thereby allowing less 
room for the peptide to mediate cell interactions and/or (ii) 
such affinity properties between KRSR and the surface might 
alter the peptide three-dimensional structures essential for 
osteoblast adhesion. 
Results of this study demonstrating the successful 
immobilization of peptides onto calcium phosphate-based 
particles can be extrapolated to include other bioactive 
molecules and growth factors. In this manner, the techniques 
used in this study could allow the calcium phosphate-based 
particles created here to have different degrees of degradation 
to be utilized in a wide range of drug delivery applications; 
degradation can be further controlled by the inclusion of 
pores. Often, for orthopedic applications (such as fighting 
cancer or reversing osteoporosis), calcium phosphate 
nanoparticles are the preferred drug carrier (Coleman et al 
2004). 
Lastly, it is intriguing to speculate why increased 
osteoblast adhesion occurred on nano-crystalline HA 
compared with conventional HA (materials of the same 
crystallinity and chemistry but different particle size). 
Since nanophase materials are composed of particles of 
the same atoms but fewer (less than tens of thousands) and 
smaller (less than 100nm in diameter) than conventional 
forms (which contain several billions of atoms and have 
particle sizes microns to millimeters in diameter), nanophase 
materials have unique surface properties (Webster 2006). 
In this respect, nanophase materials have higher numbers International Journal of Nanomedicine 2006:1(3) 348
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of atoms at the surface compared with bulk, greater areas 
of increased surface defects (such as edge–corner sites and 
particle boundaries), and larger proportions of delocalized 
surface electrons. Such altered surface properties will 
influence initial protein interactions that control subsequent 
cell adhesion (Webster 2006). 
Conclusion
The results of this study provided evidence that the synthesis 
of nanometer particles of crystalline HA can be useful in a 
wide range of orthopedic applications due to their ability to 
increase osteoblast adhesion and have tailorable degradation 
properties. Results further showed the ability to functionalize 
peptides not only on conventional HA but also on the 
nanophase HA and nano-amorphous calcium phosphate 
compacts; critical criteria to allow attachment of other 
bioactive molecules for numerous applications. In particular, 
the cell adhesion peptide (KRSR) was used as a model 
peptide in this study and was immobilized onto the calcium 
phosphate-based compacts via aminosilane chemistry 
followed by a maleimide cross-linker molecule. Finally, the 
peptides were immobilized to the terminal maleimide group 
by means of covalent thiol bonding. Peptide functionalization 
was characterized by a well-established XPS technique. 
Results further demonstrated that osteoblast adhesion was 
similar on unfunctionalized nano-crystalline HA compared 
with conventional HA functionalized with KRSR. In this 
manner, results from this study suggest that nano-crystalline 
HA should be further studied for applications that necessitate 
bone growth. 
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